New York – November 06, 2026 -- Navina, an AI-powered clinical intelligence platform, has appointed Dr. Joshua Newman as Chief Medical Officer as its platform reaches more than 20,000 clinicians and care team members at over 1,300 U.S. clinics, supporting the care of more than five million patient lives.
Newman brings nearly 14 years of Salesforce healthcare leadership
Newman spent almost 14 years at Salesforce, where he served as SVP and Chief Medical Officer and as SVP and Global GM of Healthcare and Life Sciences. In that role he built the company's healthcare business and its relationships with health systems and payers.
Most recently, he was Chief Strategy Officer at Alleviate.care, a physician-led hospice and palliative care organization. He began his career in clinical practice and served as an assistant professor of medicine at UCLA.
CMO will define Navina's clinical vision and shape the product roadmap
Newman will set Navina's clinical vision and act as its clinical voice with customers, partners and the wider healthcare industry. He will oversee platform implementation and adoption, and work directly with physicians and care teams to translate their experience into the product roadmap.
He will also partner with go-to-market teams to support customers and prospects. He will represent the company in industry discussions on AI adoption and on technology's role in population health and patient outcomes.
Navina cites 86% usage rate among clients including Privia Health and agilon health
Navina reports an 86% usage rate. Its customers include Privia Health, agilon health and Summit Health.
Newman framed the platform's value around value-based care, where clinicians must act on information scattered across thousands of pages of records and then face documentation work. In his words, Navina "solves that at the point of care, inside the workflow."
Co-founder and CEO Ronen Lavi said Newman will help keep the physician perspective central to what Navina builds and how it brings the product into care delivery.